Carriers in the topical treatment of skin disease

Handbook of Experimental Pharmacology

Volumn 197, Issue , 2010, Pages 435-468

  Korting, Hans Christian ^a   Schäfer Korting, Monika ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Cutaneous absorption; Drug carriers; Liposome; Microemulsion; Polymer particles; Skin penetration; Solid lipid nanoparticle

Indexed keywords

ANTIANDROGEN; ANTIINFECTIVE AGENT; AVOBENZONE; AZELAIC ACID; BENZOYL PEROXIDE; CARBON NANOTUBE; CHITOSAN; DENDRIMER; DICLOFENAC; ECONAZOLE; FENTANYL; FLUOROURACIL; GLUCOCORTICOID; GLYCEROL BEHENATE; GLYCEROL PALMITOSTEARATE; ISOTRETINOIN; LIPID; LIPOSOME; NANOPARTICLE; NIOSOME; POLYGLACTIN; POLYLACTIC ACID; RETINOIC ACID; RETINOID; SOLID LIPID NANOPARTICLE; SUFENTANIL; TITANIUM DIOXIDE; TRISTEARIN; UNINDEXED DRUG; ZINC OXIDE; DERMATOLOGICAL AGENT; DRUG CARRIER;

ACNE VULGARIS; ACTINIC KERATOSIS; ATOPIC DERMATITIS; BURNING SENSATION; CYTOTOXICITY; DERMATITIS; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RELEASE; DRUG UPTAKE; HUMAN; LIPID BLOOD LEVEL; NANOEMULSION; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PSORIASIS VULGARIS; REVIEW; SIDE EFFECT; SKIN ABSORPTION; SKIN DISEASE; SKIN IRRITATION; SKIN PERMEABILITY; SKIN STRUCTURE; TOPICAL DRUG ADMINISTRATION; ANIMAL; CHEMISTRY; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ADMINISTRATION, CUTANEOUS; ANIMALS; BIOLOGICAL TRANSPORT; CHEMISTRY, PHARMACEUTICAL; DERMATOLOGIC AGENTS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; SKIN ABSORPTION; SKIN DISEASES;

EID: 77953268620     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-00477-3_15     Document Type: Review

References (135)

1. Abramovic Z, Sustarsic U, Teskac K, Sentjurc M, Kristl J (2008) Influence of nanosized delivery systems with benzyl nicotinate and penetration enhancers on skin oxygenation. Int J Pharm 359:220-227
2. Akiyama M, Shimizu H (2008) An update on molecular aspects of the non-syndromic ichthyoses. Exp Dermatol 17:373-382
3. Alvarez-Roman R, Barre G, Guy RH, Fessi H (2001) Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection. Eur J Pharm Biopharm 52:191-195
4. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H (2004a) Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res 21:1818-1825
5. Alvarez-Roman R, Naik A, Kalia YN, Guy RH, Fessi H (2004b) Skin penetration and distribution of polymeric nanoparticles. J Control Release 99:53-62
6. Anigbogu AN, Williams AC, Barry BW (1996) Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment. J Pharm Pharmacol 48:357-366
7. Anton N, Benoit JP, Saulnier P (2008) Design and production of nanoparticles formulated from nano-emulsion templates - a review. J Control Release 128:185-199
8. Barry BW (2004) Breaching the skin's barrier to drugs. Nature Biotechnol 22:165-167
9. Bashir SJ, Chew AL, Anigbogu A, Dreher F, Maibach HI (2001) Physical and physiological effects of stratum corneum tape stripping. Skin Res Technol 7:40-48
10. Bernard E, Dubois JL, Wepierre J (1997) Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes. J Pharm Sci 86:573-578
11. Blaschke T, Kankate L, Kramer KD (2007) Structure and dynamics of drug-carrier systems as studied by parelectric spectroscopy. Adv Drug Deliv Rev 59:403-410
12. Blaschke T, Spangenberg T, Dathe M, Mehnert W, Korting HC, Schäfer-Korting M, Kramer KD (in press) Interaction of drug-carrier systems with targets - a study using atomic force microscopy
13. Bouwstra JA, Honeywell-Nguyen PL (2002) Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 54(Suppl 1):S41-55
14. Bouwstra JA, Ponec M (2006) The skin barrier in healthy and diseased state. Biochim Biophys Acta 1758:2080-2095
15. Braem C, Blaschke T, Panek-Minkin G, Herrmann W, Schlupp P, Paepenmüller T, Müller-Goyman C, Mehnert W, Bittl R, Schäfer-Korting M, Kramer KD (2007) Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. J Control Release 119:128-135
16. Bronaugh RL, Franz TJ (1986) Vehicle effects on percutaneous absorption: in vivo and in vitro comparisons with human skin. Br J Dermatol 115:1-11
17. Bronaugh RL, Stewart RF (1985) Methods for in vitro percutaneous absorption studies IV: the flow-through diffusion cell. J Pharm Sci 74:64-67
18. Cevc G (2004) Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 56:675-711
19. Chen H, Chang X, Du D, Liu W, Liu J, Weng T, Yang Y, Xu H, Yang X (2006) Podophyllotoxinloaded solid lipid nanoparticles for epidermal targeting. J Control Release 110:296-306
20. Choi MJ, Maibach HI (2005) Role of ceramides in barrier function of healthy and diseased skin. Am J Clin Dermatol 6:215-223
21. Date AA, Naik B, Nagarsenker MS (2006) Novel drug delivery systems: potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol 19:2-16
22. Dayan N, Touitou E (2000) Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21:1879-1885
23. Dreher F, Modjtahedi BS, Modjtahedi SP, Maibach HI (2005) Quantification of stratum corneum removal by adhesive tape stripping by total protein assay in 96-well microplates. Skin Res Technol 11:97-101
24. Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK (2007) Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 123:148-154
25. Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM (2007) Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 332:1-16
26. Fang JY, Hwang TL, Fang CL, Chiu HC (2003) In vitro and in vivo evaluations of the efficacy and safety of skin permeation enhancers using flurbiprofen as a model drug. Int J Pharm 255:153-166
27. Feldmann RJ, Maibach HI (1969) Percutaneous penetration of steroids in man. J Invest Dermatol 52:89-94
28. Fesq H, Lehmann J, Kontny A, Erdmann I, Theiling K, Rother M, Ring J, Cevc G, Abeck D (2003) Improved risk-benefit ratio for topical triamcinolone acetonide in transfersome in comparison with equipotent cream and ointment: a randomized controlled trial. Br J Dermatol 149:611-619
29. Geinoz S, Guy RH, Testa B, Carrupt PA (2004) Quantitative structure-permeation relationships (QSPeRs) to predict skin permeation: a critical evaluation. Pharm Res 21:83-92
30. Gloor M (2004) How do dermatological vehicles influence the horny layer? Skin Pharmacol Physiol 17:267-273
31. Grimes PE (2004) A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation. Cutis 74:362-368
32. Haag R, Kratz F (2006) Polymer therapeutics: concepts and applications. Angew Chem (Int Ed) 45:1198-1215
33. Heard CM, Monk BV, Modley AJ (2003) Binding of primaquine to epidermal membranes and keratin. Int J Pharm 257:237-244
34. Hoffman RM (1998) Topical liposome targeting of dyes, melanins, genes, and proteins selectively to hair follicles. J Drug Target 5:67-74
35. Hu FQ, Yuan H, Zhang HH, FangM(2002) Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm 239:121-128
36. Hueber F, Schaefer H, Wepierre J (1994) Role of transepidermal and transfollicular routes in percutaneous absorption of steroids: in vitro studies on human skin. Skin Pharmacol 7:237-244
37. Iannuccelli V, Coppi G, Sergi S, Mezzena M, Scalia S (2008) In vivo and in vitro skin permeation of butyl methoxydibenzoylmethane from lipospheres. Skin Pharmacol Physiol 21:30-38
38. Iraji F, Momeni A, Naji SM, Siadat AH (2006) The efficacy of topical cyproterone acetate alcohol lotion versus placebo in the treatment of the mild to moderate acne vulgaris: a double blind study. Dermatol Online J 12:26
39. Jacobi U, Gautier J, Sterry W, Lademann J (2005a) Gender-related differences in the physiology of the stratum corneum. Dermatology 211:312-317
40. Jacobi U, Weigmann HJ, Ulrich J, Sterry W, Lademann J (2005b) Estimation of the relative stratum corneum amount removed by tape stripping. Skin Res Technol 11:91-96
41. Jain SK, Chourasia MK, Masuriha R, Soni V, Jain A, Jain NK, Gupta Y (2005) Solid lipid nanoparticles bearing flurbiprofen for transdermal delivery. Drug Deliv 12:207-215
42. Jelvehgari M, Siahi-Shadbad MR, Azarmi S, Martin GP, Nokhodchi A (2006) The microsponge delivery system of benzoyl peroxide: preparation, characterization and release studies. Int J Pharm 308:124-132
43. Jenning V, Gysler A, Schäfer-Korting M, Gohla SH (2000a) Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin. Eur J Pharm Biopharm 49:211-218
44. Jenning V, Schäfer-Korting M, Gohla S (2000b) Vitamin A-loaded solid lipid nanoparticles for topical use: drug release properties. J Control Release 66:115-126
45. Jores K, Haberland A, Wartewig S, Mäder K, Mehnert W (2005) Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. Pharm Res 22:1887-1897
46. Kalariya M, Padhi BK, Chougule M, Misra A (2005) Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications. Indian J Exp Biol 43:233-240
47. Karande P, Jain A, Mitragotri S (2004) Discovery of transdermal penetration enhancers by highthroughput screening. Nature Biotechnol 22:192-197
48. Katritzky AR, Dobchev DA, Fara DC, Hur E, Tamm K, Kurunczi L, Karelson M, Varnek A, Solov'ev VP (2006) Skin permeation rate as a function of chemical structure. J Med Chem 49:3305-3314
49. Korting HC, Klövekorn W, Klövekorn G, and the Ecosome Collaborative Study Group (1997) Comparative efficacy and tolerability of econazole liposomal gel 1%, branded econazol convetional cream 1% and generic clotrimazole cream 1% in tinea pedis. Clin Drug Invest 14:286-293
50. Korting HC, Patzak U, Schaller M, Maibach HI (1998) A model of human cutaneous candidosis based on reconstructed human epidermis for the light and electron microscopic study of pathogenesis and treatment. J Infect 36:259-267
51. Korting HC, Unholzer A, Schäfer-Korting M, Tausch I, Gassmueller J, Nietsch KH (2002) Different skin thinning potential of equipotent medium-strength glucocorticoids. Skin Pharmacol Appl Skin Physiol 15:85-91
52. Krämer M, Stumbe JF, Türk H, Krause S, Komp A, Delineau L, Prokhorova S, Kautz H, Haag R (2002) pH-responsive molecular nanocarriers based on dendritic core-shell architectures. Angew Chem (Int Ed) 41:4252-4256
53. Kreilgaard M (2002) Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev 54(Suppl 1):S77-98
54. Kriftner RW (1992) Liposome production: The ethanol injection technique and the development of the first approved liposome dermatic. In: Braun-Falco O, Korting HC, Maibach HI (eds) Griesbach conference liposome dermatics. Springer, Berlin, pp 91-100
55. Küchler S, Radowski MR, Blaschke T, Dathe M, Plendl J, Haag R, Schäfer-Korting M, Kramer KD (2008) Nanoparticles for skin penetration enhancement - a comparison of a dendritic coremultishell- nanotransporter and solid lipid nanoparticles. Eur J Pharm Biopharm 71:243-250
56. Lademann J, Richter H, Golz K, Zastrow L, Sterry W, Patzelt A (2008) Influence of microparticles on the homogeneity of distribution of topically applied substances. Skin Pharmacol Physiol 21:274-282
57. Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, Weiss B, Schaefer UF, Lehr CM, Wepf R, Sterry W (2007) Nanoparticles - an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 66:159-164
58. Lademann J, Rudolph A, Jacobi U, Weigmann HJ, Schaefer H, Sterry W, Meinke M (2004) Influence of nonhomogeneous distribution of topically applied UV filters on sun protection factors. J Biomed Opt 9:1358-1362
59. Lademann J, Weigmann H, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W (1999) Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 12:247-256
60. Lademann J, Weigmann HJ, Schanzer S, Richter H, Audring H, Antoniou C, Tsikrikas G, Gers-Barlag H, Sterry W (2005) Optical investigations to avoid the disturbing influences of furrows and wrinkles quantifying penetration of drugs and cosmetics into the skin by tape stripping. J Biomed Opt 10:54015
61. Lakshmi PK, Devi GS, Bhaskaran S, Sacchidanand S (2007) Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies. Indian J Dermatol Venereol Leprol 73:157-161
62. Lehmann L, Keipert S, Gloor M (2001) Effects of microemulsions on the stratum corneum and hydrocortisone penetration. Eur J Pharm Biopharm 52:129-136
63. Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X (2007) Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm 328:191-195
64. Löffler H, Dreher F, Maibach HI (2004) Stratum corneum adhesive tape stripping: influence of anatomical site, application pressure, duration and removal. Br J Dermatol 151:746-752
65. Lombardi Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting HC, Danker K, Röder B, Kramer KD, Schäfer-Korting M (2005) Lipid nanoparticles for skin penetration enhancement - correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J Control Release 110:151-163
66. Lombardi Borgia S, Schlupp P, Mehnert W, Schäfer-KortingM(2008) In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use. Eur J Pharm Biopharm 68:380-389
67. Luengo J, Weiss B, Schneider M, Ehlers A, Stracke F, Konig K, Kostka KH, Lehr CM, Schaefer UF (2006) Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol Physiol 19:190-197
68. Majumdar S, Thomas J, Wasdo S, Sloan KB (2007) The effect of water solubility of solutes on their flux through human skin in vitro. Int J Pharm 329:25-36
69. McKenzie AW, Stoughton RB (1962) A method for comparing percutaneous absorption of steroids. Arch Dermatol 86:608-610
70. Mei Z, Chen H, Weng T, Yang Y, Yang X (2003) Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 56:189-196
71. Menter A, Vamvakias G, Jorizzo J (2008) One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratoses. Cutis 81:509-516
72. Miyazaki S, Takahashi A, Kubo W, Bachynsky J, Loebenberg R (2003) Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J Pharm Pharm Sci 6:238-245
73. Moll KP, Stosser R, Herrmann W, Borchert HH, Utsumi H (2004) In vivo ESR studies on subcutaneously injected multilamellar liposomes in living mice. Pharm Res 21:2017-2024
74. Moser K, Kriwet K, Froehlich C, Naik A, Kalia YN, Guy RH (2001) Permeation enhancement of a highly lipophilic drug using supersaturated systems. J Pharm Sci 90:607-616
75. Moss GP, Dearden JC, Patel H, Cronin MT (2002) Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol In Vitro 16:299-317
76. Müller RH, Petersen RD, Hommoss A, Pardeike J (2007) Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 59:522-530
77. Müller RH, Radtke M, Wissing SA (2002) Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 54 (Suppl 1):S131-155
78. Müller RH, Rühl D, Runge S, Schulze-Forster K, Mehnert W (1997) Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm Res 14:458-462
79. Münster U, Nakamura C, Haberland A, Jores K, Mehnert W, Rummel S, Schaller M, Korting HC, Zouboulis Ch C, Blume-Peytavi U, Schäfer-Korting M (2005) RU 58841-myristate - prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie 60:8-12
80. Mutschler E, Geisslinger G, Kroemer HK, Ruth P, Schäfer-Korting M (2008) Mutschler Arzneimittelwirkungen: Lehrbuch der Pharmakologie und Toxikologie. Wissenschaftliche Verlagsgesellschaft, Stuttgart
81. OECD (2004a) Test Guideline 427: Skin Absorption: in vivo Method. Adopted on 13th April 2004
82. OECD (2004b) Test Guideline 428: Skin Absorption: in vitro Method. Adopted on 13th April 2004
83. Ogiso T, Niinaka N, Iwaki M (1996) Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. J Pharm Sci 85:57-64
84. Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J (2004) Variations of hair follicle size and distribution in different body sites. J Invest Dermatol 122:14-19
85. Ottaviani G, Martel S, Carrupt PA (2007) In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities. J Med Chem 50:742-748
86. Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M (2008) Innovative bolasurfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharm 353:233-242
87. Patravale VB, Mandawgade SD (2008) Novel cosmetic delivery systems: an application update. Int J Cosmet Sci 30:19-33
88. Pelchrzim R, Weigmann HJ, Schaefer H, Hagemeister T, Linscheid M, Shah VP, Sterry W, Lademann J (2004) Determination of the formation of the stratum corneum reservoir for two different corticosteroid formulations using tape stripping combined with UV/VIS spectroscopy. J Dtsch Dermatol Ges 2:914-919
89. Pershing LK, Silver BS, Krueger GG, Shah VP, Skelley JP (1992) Feasibility of measuring the bioavailability of topical betamethasone dipropionate in commercial formulations using drug content in skin and a skin blanching bioassay. Pharm Res 9:45-51
90. Pilgram GS, van der Meulen J, Gooris GS, Koerten HK, Bouwstra JA (2001) The influence of two azones and sebaceous lipids on the lateral organization of lipids isolated from human stratum corneum. Biochim Biophys Acta 1511:244-254
91. Rother M, Lavins BJ, Kneer W, Lehnhardt K, Seidel EJ,Mazgareanu S (2007) Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Ann RheumDis 66:1178-1183
92. Rougier A, Lotte C, Maibach HI (1987) In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method. J Pharm Sci 76:451-454
93. Roy SD, Flynn GL (1990) Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil. Pharm Res 7:842-847
94. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA (2006) Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci 91:159-165
95. Sanna V, Gavini E, Cossu M, Rassu G, Giunchedi P (2007) Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and invivo studies. J Pharm Pharmacol 59:1057-1064
96. Santos Maia C, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Schäfer-Korting M (2002) Drug targeting by solid lipid nanoparticles for dermal use. J Drug Targeting 10:489-495
97. Santos P, Watkinson AC, Hadgraft J, Lane ME (2008) Application of microemulsions in dermal and transdermal drug delivery. Skin Pharmacol Physiol 21:246-259
98. SCCP (2007) The Scientific Committee on Cosmetic Products (SCCP) Opinion on safety of nanomaterials in cosmetic products. http://ec.europa.eu/health/ph- risk/committees/04-sccp/ docs/sccp-o-123.pdf
99. Schaefer H, Lademann J (2001) The role of follicular penetration. A differential view. Skin Pharmacol Appl Skin Physiol 14(Suppl 1):23-27
100. Schäfer-Korting M, Bock U, Diembeck W, Düsing HJ, Gamer A, Haltner-Ukomadu E, Hoffmann C, Kaca M, Kamp H, Kersen S, Kietzmann M, Korting HC, Krächter HU, Lehr CM, Liebsch M, Mehling A, Müller-Goymann C, Netzlaff F, Niedorf F, Rübbelke MK, Schäfer U, Schmidt E, Schreiber S, Spielmann H, Vuia A, Weimer M (2008a) The use of reconstructed human epidermis for skin absorption testing: results of the validation study. Altern Lab Anim 36:161-187
101. Schäfer-Korting M, Bock U, Gamer A, Haberland A, Haltner-Ukomadu E, Kaca M, Kamp H, Kietzmann M, Korting HC, Krächter HU, Lehr CM, Liebsch M, Mehling A, Netzlaff F, Niedorf F, Rübbelke MK, Schäfer U, Schmidt E, Schreiber S, Schröder KR, Spielmann H, Vuia A (2006) Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study. Altern Lab Anim 34:283-294
102. Schäfer-Korting M, Korting HC, Kerscher MJ, Lenhard S (1993) Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids. Clin Pharmacol Ther 54:448-456
103. Schäfer-Korting M, Mahmoud A, Lombardi Borgia S, Brüggener B, Kleuser B, Schreiber S, Mehnert W (2008b) Reconstructed epidermis and full-thickness skin for absorption testing: Influences of vehicles on steroid permeation. Altern Lab Anim 36:441-452
104. Schäfer-Korting M, Mehnert W, Korting HC (2007) Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 59:427-443
105. Schäfer-Korting M, Schmid MH, Korting HC (1996) Topical glucocorticoids with improved riskbenefit ratio. Rationale of a new concept. Drug Saf 14:375-385
106. Schaller M, Preidel H, Januschke E, Korting HC (1999) Light and electron microscopic findings in a model of human cutaneous candidosis based on reconstructed human epidermis following the topical application of different econazole formulations. J Drug Target 6:361-372
107. Schmook FP, Meingassner JG, Billich A (2001) Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm 215:51-56
108. Schöler N, Hahn H, Müller RH, Liesenfeld O (2002) Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages. Int J Pharm 231:167-176
109. Schöler N, Olbrich C, Tabatt K, Müller RH, Hahn H, Liesenfeld O (2001) Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int J Pharm 221:57-67
110. Schreiber S, Mahmoud A, Vuia A, Rübbelke MK, Schmidt E, Schaller M, Kandarova H, Haberland A, Schäfer UF, Bock U, Korting HC, Liebsch M, Schäfer-Korting M (2005) Reconstructed epidermis versus human and animal skin in skin absorption studies. Toxicol In Vitro 19:813-822
111. Shah VP (2001) Progress in methodologies for evaluating bioequivalence of topical formulations. Am J Clin Dermatol 2:275-280
112. Shah VP, Flynn GL, Yacobi A, Maibach HI, Bon C, Fleischer NM, Franz TJ, Kaplan SA, Kawamoto J, Lesko LJ, Marty JP, Pershing LK, Schaefer H, Sequeira JA, Shrivastava SP, Wilkin J, Williams RL (1998) Bioequivalence of topical dermatological dosage forms - methods of evaluation of bioequivalence. Pharm Res 15:167-171
113. Sivaramakrishnan R, Nakamura C, Mehnert W, Korting HC, Kramer KD, Schäfer-Korting M (2004) Glucocorticoid entrapment into lipid carriers - characterisation by parelectric spectroscopy and influence on dermal uptake. J Control Release 97:493-502
114. Song C, Liu S (2005) A new healthy sunscreen system for human: solid lipid nanoparticles as carrier for 3, 4, 5-trimethoxybenzoylchitin and the improvement by adding vitamin E. Int J Biol Macromol 36:116-119
115. Stecova J, Mehnert W, Blaschke T, Kleuser B, Sivaramakrishnan R, Zouboulis CC, Seltmann H, Korting HC, Kramer KD, Schäfer-Korting M (2007) Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm Res 24:991-1000
116. Stern ST, McNeil SE (2008) Nanotechnology safety concerns revisited. Toxicol Sci 101:4-21
117. Takahashi A, Suzuki S, Kawasaki N, Kubo W, Miyazaki S, Loebenberg R, Bachynsky J, Attwood D (2002) Percutaneous absorption of non-steroidal anti-inflammatory drugs from in situ gelling xyloglucan formulations in rats. Int J Pharm 246:179-186
118. Teichmann A, Jacobi U, Ossadnik M, Richter H, Koch S, Sterry W, Lademann J (2005) Differential stripping: determination of the amount of topically applied substances penetrated into the hair follicles. J Invest Dermatol 125:264-269
119. Teichmann A, Ossadnik M, Richter H, Sterry W, Lademann J (2006) Semiquantitative determination of the penetration of a fluorescent hydrogel formulation into the hair follicle with and without follicular closure by microparticles by means of differential stripping. Skin Pharmacol Physiol 19:101-105
120. Thong HY, Zhai H, Maibach HI (2007) Percutaneous penetration enhancers: an overview. Skin Pharmacol Physiol 20:272-282
121. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H, Blume-Peytavi U (2004) Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 123:168-176
122. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M (2000) Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403-418
123. Trotta M, Peira E, Carlotti ME, Gallarate M (2004) Deformable liposomes for dermal administration of methotrexate. Int J Pharm 270:119-125
124. Tsai JC, Lin CY, Sheu HM, Lo YL, Huang YH (2003) Noninvasive characterization of regional variation in drug transport into human stratum corneum in vivo. Pharm Res 20:632-638
125. Ulrich C, Degen A, Patel MJ, Stockfleth E (2008) Sunscreens in organ transplant patients. Nephrol Dial Transplant 23:2712
126. Vickers CF, Fritsch WC (1963) A hazard of plastic film therapy. Arch Dermatol 87:633-636
127. Wagner H, Kostka KH, Adelhardt W, Schaefer UF (2004) Effects of various vehicles on the penetration of flufenamic acid into human skin. Eur J Pharm Biopharm 58:121-129
128. Wagner H, Kostka KH, Lehr CM, Schaefer UF (2002a) Correlation between stratum corneum/ water-partition coefficient and amounts of flufenamic acid penetrated into the stratum corneum. J Pharm Sci 91:1915-1921
129. Wagner H, Kostka KH, Lehr CM, Schaefer UF (2002b) Human skin penetration of flufenamic acid: in vivo/in vitro correlation (deeper skin layers) for skin samples from the same subject. J Invest Dermatol 118:540-544
130. Weigmann H, Lademann J, Meffert H, Schaefer H, Sterry W (1999) Determination of the horny layer profile by tape stripping in combination with optical spectroscopy in the visible range as a prerequisite to quantify percutaneous absorption. Skin Pharmacol Appl Skin Physiol 12:34-45
131. Weigmann HJ, Jacobi U, Antoniou C, Tsikrikas GN, Wendel V, Rapp C, Gers-Barlag H, Sterry W, Lademann J (2005) Determination of penetration profiles of topically applied substances by means of tape stripping and optical spectroscopy: UV filter substance in sunscreens. J Biomed Opt 10:14009
132. Weinstein GD, McCullough JL, Olsen E (1989) Topical methotrexate therapy for psoriasis. Arch Dermatol 125:227-230
133. Weyenberg W, Filev P, Van den Plas D, Vandervoort J, De Smet K, Sollie P, Ludwig A (2007) Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application. Int J Pharm 337:291-298
134. Wilsmann-Theis D, Hagemann T, Jordan J, Bieber T, Novak N (2008) Facing psoriasis and atopic dermatitis: are there more similarities or more differences? Eur J Dermatol 18:172-180
135. Zhang LW, Yu WW, Colvin VL, Monteiro-Riviere NA (2008) Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol 228:200-211